Delhi HC rejects BMS plea to ban Ranbaxy generic

THE Delhi High Court has turned down a plea by US pharma major Bristol-Myers Squibb (BMS) to ban India

Read More
Publication Date: 
25/03/2010
Economic Times (New Delhi)
Tags:
Health, Drugs, Drug Industry, Patents, High Court, Delhi, Ranbaxy Pharmaceuticals